Estimation of salivary IL-6 and calprotectin in patients with ulcerative colitis

Inflammatory bowel disease (IBD) is chronic inflammation of the gastrointestinal tract (GIT) it includes two-condition Crohn’s disease (CD) and ulcerative colitis (UC) the prolonged inflammation may cause invasion of the multiple layers of the intestinal walls result in GIT damage. The current stud...

Full description

Saved in:
Bibliographic Details
Main Authors: Fadhel A. Abdullah, Maha A. Mahmood
Format: Article
Language:English
Published: College of Medicine University of Baghdad 2024-12-01
Series:مجلة كلية الطب
Subjects:
Online Access:https://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/2031
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594678786031616
author Fadhel A. Abdullah
Maha A. Mahmood
author_facet Fadhel A. Abdullah
Maha A. Mahmood
author_sort Fadhel A. Abdullah
collection DOAJ
description Inflammatory bowel disease (IBD) is chronic inflammation of the gastrointestinal tract (GIT) it includes two-condition Crohn’s disease (CD) and ulcerative colitis (UC) the prolonged inflammation may cause invasion of the multiple layers of the intestinal walls result in GIT damage. The current study was carried out in Baghdad teaching hospital and gastroenterology hospital from November 2021 to May 2022.  In order to show if the diagnostic marker of IBD which are IL6& calprotectin are rises in saliva as in sera and if there are significant differences in the levels of those markers between UC patients and healthy control subjects. The subjects included twenty five patients suffering from ulcerative colitis and twenty five healthy individuals representing the control group. All of them having ages ranged between 20-55 years. The recent study was measured the levels of Interleukin-6 (IL-6) and calprotectin in saliva of UC patients using ELISA method. The present results showed a significant increase in the levels of both (IL-6) and calprotectin  in UC patients when compared with that of control group (P=<0.05).Moreover, this study was found a significant positive correlation between IL-6 levels and age in all study groups (UC and control) (P <0.05) and between IL-6 and calprotectin in UC patients(p<0.05).
format Article
id doaj-art-31808284694b4d1b8bbb8543234da911
institution Kabale University
issn 0041-9419
2410-8057
language English
publishDate 2024-12-01
publisher College of Medicine University of Baghdad
record_format Article
series مجلة كلية الطب
spelling doaj-art-31808284694b4d1b8bbb8543234da9112025-01-19T12:24:10ZengCollege of Medicine University of Baghdadمجلة كلية الطب0041-94192410-80572024-12-0166410.32007/jfacmedbagdad.6612031Estimation of salivary IL-6 and calprotectin in patients with ulcerative colitisFadhel A. Abdullah0https://orcid.org/0000-0003-4027-8405Maha A. Mahmood1https://orcid.org/0000-0003-3516-1309Department of Basic Sciences College of Dentistry, University of Baghdad, Baghdad, Iraq.Department of Basic Sciences College of Dentistry-University of Baghdad, Baghdad, Iraq Inflammatory bowel disease (IBD) is chronic inflammation of the gastrointestinal tract (GIT) it includes two-condition Crohn’s disease (CD) and ulcerative colitis (UC) the prolonged inflammation may cause invasion of the multiple layers of the intestinal walls result in GIT damage. The current study was carried out in Baghdad teaching hospital and gastroenterology hospital from November 2021 to May 2022.  In order to show if the diagnostic marker of IBD which are IL6& calprotectin are rises in saliva as in sera and if there are significant differences in the levels of those markers between UC patients and healthy control subjects. The subjects included twenty five patients suffering from ulcerative colitis and twenty five healthy individuals representing the control group. All of them having ages ranged between 20-55 years. The recent study was measured the levels of Interleukin-6 (IL-6) and calprotectin in saliva of UC patients using ELISA method. The present results showed a significant increase in the levels of both (IL-6) and calprotectin  in UC patients when compared with that of control group (P=<0.05).Moreover, this study was found a significant positive correlation between IL-6 levels and age in all study groups (UC and control) (P <0.05) and between IL-6 and calprotectin in UC patients(p<0.05). https://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/2031Salivary IL-6, calprotectin, ulcerative colitis
spellingShingle Fadhel A. Abdullah
Maha A. Mahmood
Estimation of salivary IL-6 and calprotectin in patients with ulcerative colitis
مجلة كلية الطب
Salivary IL-6, calprotectin, ulcerative colitis
title Estimation of salivary IL-6 and calprotectin in patients with ulcerative colitis
title_full Estimation of salivary IL-6 and calprotectin in patients with ulcerative colitis
title_fullStr Estimation of salivary IL-6 and calprotectin in patients with ulcerative colitis
title_full_unstemmed Estimation of salivary IL-6 and calprotectin in patients with ulcerative colitis
title_short Estimation of salivary IL-6 and calprotectin in patients with ulcerative colitis
title_sort estimation of salivary il 6 and calprotectin in patients with ulcerative colitis
topic Salivary IL-6, calprotectin, ulcerative colitis
url https://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/2031
work_keys_str_mv AT fadhelaabdullah estimationofsalivaryil6andcalprotectininpatientswithulcerativecolitis
AT mahaamahmood estimationofsalivaryil6andcalprotectininpatientswithulcerativecolitis